-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Amylyx Pharmaceuticals, Maintains $55 Price Target

Benzinga·11/19/2026 12:57:56
Listen to the news
HC Wainwright & Co. analyst Ananda Ghosh reiterates Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and maintains $55 price target.